Booster shots in COVID-19 debate highlight science over politics
The piece explains booster concepts and varying global stances with input from UPenn immunologist Drew Weissman. It notes Pfizer seeks U.S. and EU approval for a booster after Israel data, while CDC and FDA say current vaccines suffice for now. It discusses who would need boosters and policy considerations.
MENTIONED IN THIS ARTICLE
Pfizer
Britain
Israel
U.S. Centers For Disease Control and Prevention
The
Food and Drug Administration
University of Pennsylvania
Drew Weissman
CDC
FDA
Johnson & Johnson
Weissman
Procrastination Causes and Expert Coping Tips
A range of factors drive procrastination from fear and low self esteem to thrill seeking and indecision. Experts link procrastination to higher stress, sleep problems, headaches, heart issues, and delayed preventive care. Suggestions include self compassion, meaningful purpose, starting small, deadlines, task order, interruption control, mindful knowledge of procrasti clearing, rewards, and enlisting external accountability.
MENTIONED IN THIS ARTICLE
Sirois
Ferrari
Journal of Behavioral Medicine
Gretchen Rubin
Rubin
Tarantula venom eyed as chronic pain treatment
UC Davis researchers with NIH funding study Peruvian green velvet tarantula venom for blocking Nav1.7 pain channels. Led by Bruce Hammock and Heike Wulff, the team uses Rosetta to design peptide variants aiming to match opioid potency without addiction, addressing a potential market of millions affected by pain.
MENTIONED IN THIS ARTICLE
Sacramento
Calif
National Institutes of Health
University of California At Davis
Bruce Hammock
Hammock
U.S. Food and Drug Administration
Heike Wulff
Yarov-Yarovov
Davis
United States
Also Mentioned on This Page
Sarah Gantz
Philadelphia Inquirer
Lesbia Ruiz
Theresa Williams
Sacred Heart Church
Highlandtown
Baltimore Sun
Sacramento Bee